Autopsy report · NCT01135537

Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants

“The study was closed before 2017 due to inconclusive results from Lab”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months after it had already started.
• Ran for about 4 years 2 months before it stopped.
• 30 participants enrolled.
• Results were posted on the registry 5 years 10 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

The Hospital for Sick Children

Sponsor type

University, hospital or other

Conditions

Malignancy; Metabolic Disease; Genetic Disorder

Interventions

Thymoglobulin (rATG)

Participants

30

Sites

1

Countries

Canada

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.